2016 report on Hawaiian monk seal vaccination program
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

The NOAA IR serves as an archival repository of NOAA-published products including scientific findings, journal articles, guidelines, recommendations, or other information authored or co-authored by NOAA or funded partners. As a repository, the NOAA IR retains documents in their original published format to ensure public access to scientific information.
i

2016 report on Hawaiian monk seal vaccination program

Filetype[PDF-254.65 KB]


Details You May Also Like

Details:

  • Corporate Authors:
    Pacific Islands Fisheries Science Center (U.S.)
  • NOAA Program & Office:
  • Description:
    "The Merial monovalent Purevax® canarypox-vectored recombinant distemper vaccine, labeled for ferrets, was previously tested for safety and seroconversion in captive harbor seals (Quinley et al. 2013) and Hawaiian monk seals (Yochem and Gulland, pers. comm.) before going on indefinite backorder in 2013. In late 2015, Merial made a limited quantity of Purevax available again. Given the 2015 window of availability and results of the epidemiological model, it was decided that use on wild HMS was appropriate in order to begin implementing a prophylactic vaccination strategy to protect this species from a devastating morbillivirus outbreak. Thus, the 2016 vaccination program was designed to: (a) re-confirm safety in HMS in controlled settings (i.e., rehabilitation) using the currently available Purevax product; (b) establish capacity to further evaluate long-term antibody titer levels in a subset of seals; and (c) implement prophylactic vaccination of free-ranging HMS, with an initial focus on achieving herd immunity on Oahu. This document summarizes 2016 Hawaiian monk seal vaccination efforts (Johanos, 2016a) and serum antibody findings (Kaufman, 2016). Monk seal demographic data (Johanos, 2016 b-e) were utilized during study design and implementation, and provided context for results. All activities were conducted under NMFS Permits 16632 and 16632-01"--Background (paragraphs 4 and 5). [doi:10.7289/V5/DR-PIFSC-17-010 (http://dx.doi.org/10.7289/V5/DR-PIFSC-17-010)]
  • Content Notes:
    "Issued 24 March 2017."

    "Report period: January 1, 2016-December 31, 2016."

    System requirements: Adobe Acrobat Reader.

    Includes bibliographical references (pages 10-12).

  • Keywords:
  • Series:
    PIFSC data report ; DR-17-010
  • DOI:
  • Document Type:
    Technical Report
  • Place as Subject:
    Hawaii
  • Rights Information:
    Public Domain
  • Compliance:
    Library
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at repository.library.noaa.gov

Version 3.27.1